Sign In or Create an Account.

By continuing, you agree to the Terms of Service and acknowledge our Privacy Policy

Sparks

Will Ozempic Reduce Food Waste?

Thanks to the appetite-suppressing drug, companies are fretting about food sales. This got me thinking.

An aisle of snack food.
Heatmap Illustration/Getty Images

A year ago, I’d never heard of the diabetes drug Ozempic. Then I read the New York mag article about it, subsequently got messed up by the New York mag article about it, and basically ever since, the appetite-suppressing weight loss drug and its cousins, Wegovy and Mounjaro, have been an inescapable part of the cultural conversation (usually with an unsubtle side of moral panic thrown in). Since the start of the year, I’ve received 252 emails and newsletters that mention Ozempic, including a new one that arrived in my inbox 38 minutes ago.

The latest hysteria has been over what this newly appetite-less consumer base supposedly means for those in the appetite business. Here’s Bloomberg from last weekend:

As sales of appetite-suppressing drugs such as Ozempic and Mounjaro skyrocket, Corporate America is grappling with the question: How does a less-hungry, less-impulse-prone consumer affect my business model? [...]

John Furner, CEO of Walmart’s U.S. operations, recently said the retailer is seeing a “slight pullback in the overall basket” of food purchases as a result of the drugs, but added it’s too early to draw definitive conclusions. Conagra CEO Sean Connolly told investors this week that his company’s scientists are looking at the data, and the maker of Slim Jim and Swiss Miss could offer smaller portions in the coming years if that’s the way preferences evolve.

Separately, a Morgan Stanley report from last week also projected that up to 7% of Americans could be on appetite-suppressant medications by 2035, which could cut their individual daily calorie consumption by up to 30%.

It’s certainly the case that users of the new crop of weight loss drugs say the medications reduce “food noise” (in addition to some truly unpleasant side effects and reports of a loss of the pleasure of eating). “I don’t have cravings anymore. At all,” one woman who uses Wegovy told The New York Times. “It’s the weirdest thing.”

This got me thinking: Could appetite-suppressing drugs reduce food waste?

Food is by far the most common impulse buy, with random cravings and clever grocery store design driving many of our purchases. That said, most American food waste comes in the form of fresh foods — like fruits, vegetables, and mixed dishes — followed by dairy, meat, and then grains. Junk food, with its longer shelf life, makes up less than 10 percent of food waste, the National Post reports.

Still, just desiring less food could curb food waste since you theoretically wouldn’t feel the need to buy excess food in the first place — a shift that is at least implied by the supposedly dampened food sales Walmart is fretting over. That’s not a bad thing: It’s been estimated that 6% to 8% of human-caused greenhouse gas emissions could be reduced by ending food waste alone.

And if the proliferation of these drugs drives companies to consider pivoting to smaller portion sizes as a result, that could also be a good thing too (one of my biggest pet peeves is the way grocery store portions cater to larger families, leaving one- and two-person households with too much perishable food). Still, there is always the chance that Ozempic will potentially create more food waste as people continue to shop like they used to, but are inclined to consume less.

One thing’s for sure: Whatever the case may turn out to be, someone’s going to have a strong opinion about it.

You’re out of free articles.

Subscribe today to experience Heatmap’s expert analysis 
of climate change, clean energy, and sustainability.
To continue reading
Create a free account or sign in to unlock more free articles.
or
Please enter an email address
By continuing, you agree to the Terms of Service and acknowledge our Privacy Policy
Sparks

Burgum Doubles Down on Renewables Permitting Freeze

The Secretary of the Interior said he “absolutely” planned to appeal a ruling that lifted blocks on wind and solar approvals.

Doug Burgum.
Heatmap Illustration/Getty Images

The Trump administration is not backing down from its discriminatory policies for approving wind and solar projects. Interior Secretary Doug Burgum testified to Congress on Wednesday that his agency would appeal a recent district court ruling blocking it from enforcing these policies.

“We reject the whole premise,” Burgum said during a House Natural Resources Committee hearing.

Keep reading...Show less
Blue
Sparks

New Jersey Admits Defeat on Offshore Wind (at Least for Now)

The state has terminated an agreement to develop substations and other necessary grid infrastructure to serve the now-canceled developments.

Mike Sherrill and Donald Trump.
Heatmap Illustration/Getty Images, Library of Congress

Crucial transmission for future offshore wind energy in New Jersey is scrapped for now.

The New Jersey Board of Public Utilities on Wednesday canceled the agreement it reached with PJM Interconnection in 2021 to develop wires and substations necessary to send electricity generated by offshore wind across the state. The board terminated this agreement because much of New Jersey’s expected offshore wind capacity has either been canceled by developers or indefinitely stalled by President Donald Trump, including the now-scrapped TotalEnergies projects scrubbed in a settlement with his administration.

Keep reading...Show less
Blue
Sparks

Federal Judge Breaks Trump’s Permitting Blockade

The opinion covered a host of actions the administration has taken to slow or halt renewables development.

Donald Trump, clean energy, and columns.
Heatmap Illustration/Getty Images

A federal court seems to have struck down a swath of Trump administration moves to paralyze solar and wind permits.

U.S. District Judge Denise Casper on Tuesday enjoined a raft of actions by the Trump administration that delayed federal renewable energy permits, granting a request submitted by regional trade groups. The plaintiffs argued that tactics employed by various executive branch agencies to stall permits violated the Administrative Procedures Act. Casper — an Obama appointee — agreed in a 73-page opinion, asserting that the APA challenge was likely to succeed on the merits.

Keep reading...Show less
Blue